FrancophonIA/ELRC3.0 huggingface dataset:
English: Duloxetine Zentiva should not be used in combination with fluvoxamine, ciprofloxacin or enoxacin (i.e. potent CYP1A2 inhibitors) since the combination results in elevated plasma concentrations of duloxetine (see section 4.5).
Croatian: Duloxetine Zentiva se ne smije primjenjivati u kombinaciji s fluvoksaminom, ciprofloksacinom ili enoksacinom (tj. potentnim inhibitorima CYP1A2) jer se pri toj kombinaciji povećava koncentracija duloksetina u plazmi (vidjeti dio 4.5).
English: For patients who experience a sustained increase in blood pressure while receiving duloxetine either dose reduction or gradual discontinuation should be considered (see section 4.8).
Croatian: U bolesnika koji imaju kontinuirano povišenje krvnog tlaka za vrijeme uzimanja duloksetina mora se razmotriti ili smanjivanje doze ili postupan prekid uzimanja lijeka (vidjeti dio 4.8).
English: Medicinal products metabolised by CYP2D6
Croatian: Lijekovi koji se metaboliziraju pomoću CYP2D6
English: The efficacy of duloxetine as a treatment for diabetic neuropathic pain was established in 2 randomised, 12-week, double-blind, placebo-controlled, fixed dose studies in adults (22 to 88 years) having diabetic neuropathic pain for at least 6 months.
Croatian: Djelotvornost duloksetina u liječenju boli kod dijabetičke neuropatije utvrđena je u dva randomizirana, 12-tjedna, dvostruko slijepa, placebom kontrolirana ispitivanja fiksnih doza u odraslih (u dobi od 22 do 88 godina) koji su imali bolnu dijabetičku neuropatiju najmanje 6 mjeseci.
English: The antibiotic linezolid is a reversible non-selective MAOI and should not be given to patients treated with duloxetine (see section 4.4).
Croatian: Antibiotik linezolid je reverzibilan neselektivan MAO inhibitor i ne smije se davati bolesnicima koji se liječe duloksetinom (vidjeti dio 4.4).
English: Hyponatraemia has been reported when administering duloxetine, including cases with serum sodium lower than 110 mmol/l.
Croatian: Prijavljeni su slučajevi hiponatrijemije kod primjene duloksetina, uključujući slučajeve sa serumskom koncentracijom natrija nižom od 110 mmol/l.
English: Consequently, caution is advised when duloxetine is taken in combination with other centrally acting medicinal products or substances, including alcohol and sedative medicinal products (e.g. benzodiazepines, morphinomimetics, antipsychotics, phenobarbital, sedative antihistamines).
Croatian: Stoga se preporučuje oprez kada se duloksetin primjenjuje u kombinaciji s drugim lijekovima i tvarima koje djeluju na SŽS, uključujući alkohol i sedative (npr. benzodiazepine, morfinomimetike, antipsihotike, fenobarbital, sedativne antihistaminike).
English: The study included a 13weekdouble-blind period where patients were randomised to duloxetine 30 mg/60 mg, or placebo daily.
Croatian: Ispitivanje je uključivalo 13-tjedno dvostruko slijepo razdoblje u kojem su bolesnici bili randomizirani na dnevno primanje ili duloksetina u dozi od 30 mg/60 mg ili placeba.
English: Major Depressive Disorder
Croatian: Veliki depresivni poremećaj
English: Therefore Duloxetine Zentiva should not be administered in combination with potent inhibitors of CYP1A2 like fluvoxamine (see section 4.3).
Croatian: Stoga se Duloxetine Zentiva ne smije uzimati u kombinaciji s potentnim inhibitorima CYP1A2 poput fluvoksamina (vidjeti dio 4.3).
English: The risk of using duloxetine in combination with other CNS-active medicinal products has not been systematically evaluated, except in the cases described in this section.
Croatian: Lijekovi koji djeluju na središnji živčani sustav (SŽS) Rizici pri uzimanju duloksetina u kombinaciji s drugim lijekovima koji djeluju na SŽS nisu sustavno ocijenjeni, osim u slučajevima opisanima u ovom dijelu.
English: Do not take Duloxetine Zentiva if you:
Croatian: Nemojte uzimati Duloxetine Zentiva:
English: Duloxetine Zentiva 30 mg gastro-resistant hard capsules EU/1/15/1028/001
Croatian: Duloxetine Zentiva 30 mg želučanootporne tvrde kapsule EU/1/15/1028/001
English: • dehydration, low levels of sodium in the blood (mostly in elderly people; the symptoms may include feeling dizzy, weak, confused, sleepy or very tired, or feeling or being sick, more serious symptoms are fainting, fits or falls), syndrome of inappropriate secretion of anti-diuretic hormone (SIADH);
Croatian: • dehidracija, niske razine natrija u krvi (uglavnom u starijih osoba; simptomi mogu uključivati omaglicu, slabost, zbunjenost, pospanost ili izrazit umor, mučninu ili povraćanje; ozbiljniji simptomi su nesvjestica, napadaji ili padovi), sindrom neprimjerenog izlučivanja antidiuretskog hormona (SIADH)
English: Capsule content: sucrose, maize starch, hypromellose, talc, hypromellose acetate succinate, triethyl citrate.
Croatian: Sadržaj kapsule: saharoza, kukuruzni škrob, hipromeloza, talk, hipromelozaacetatsukcinat, trietilcitrat.
English: Do not take more than the daily amount of Duloxetine Zentiva that has been prescribed for you in one day.
Croatian: Nemojte u jednome danu uzeti više od propisane dnevne doze lijeka Duloxetine Zentiva.
English: • headache, feeling sleepy;
Croatian: • glavobolja, pospanost
English: 6 Estimated frequency of post-marketing surveillance reported adverse reactions; not observed in placebo controlled clinical trials.
Croatian: 6 Procijenjena učestalost nuspojava prijavljenih tijekom praćenja nakon stavljanja lijeka u promet; nisu uočene u placebom kontroliranim kliničkim ispitivanjima.
English: What Duloxetine Zentiva looks like and contents of the pack Duloxetine Zentiva is a gastro-resistant hard capsule.
Croatian: Kako Duloxetine Zentiva izgleda i sadržaj pakiranja Duloxetine Zentiva je želučanootporna tvrda kapsula.
English: • inflammation of the liver that may cause abdominal pain and yellowing of the skin or whites of the eyes;
Croatian: • upala jetre koja može izazvati bol u trbuhu i žutilo kože ili bjeloočnica
English: Inhibitors of CYP1A2
Croatian: Inhibitori CYP1A2
English: • suicidal behaviour, mania (over activity, racing thoughts and decreased need for sleep),
Croatian: • samoubilačko ponašanje, manija (prekomjerna aktivnost, brze misli i smanjena potreba za spavanjem), halucinacije, agresivnost i bijes
English: • sudden involuntary jerks or twitches of the muscles, sensation of restlessness or an inability to sit or stand still, feeling nervous, difficulty concentrating, changes in sense of taste, difficulty controlling movement e.g., lack of coordination or involuntary movements of the muscles,
Croatian: • iznenadni nevoljni trzaji ili grčevi mišića, osjećaj nemira ili nemogućnost mirnog sjedenja ili stajanja, nervoza, poteškoće s koncentracijom, promjene osjeta okusa, poteškoće pri kontroliranju pokreta npr. nedostatak koordinacije ili nevoljni pokreti mišića, sindrom nemirnih nogu, loša kvaliteta sna
English: Over the entire 36-week course of the study, 6 out of 333 patients initially randomized to duloxetine and 3 out of 225 patients initially randomized to fluoxetine experienced suicidal behaviour (exposure adjusted incidence 0.039 events per patient year for duloxetine, and 0.026 for fluoxetine).
Croatian: Tijekom cjelokupnog trajanja ispitivanja od 36 tjedana, suicidalno ponašanje pojavilo se u 6 od 333 bolesnika prvotno randomizirana za primanje duloksetina te u 3 od 225 bolesnika prvotno randomizirana za liječenje fluoksetinom (incidencija prilagođena za izloženost iznosila je 0,039 događaja po bolesnik-godini za duloksetin te 0,026 za fluoksetin).
English: Duloxetine Zentiva 60 mg gastro-resistant hard capsules EU/1/15/1028/004
Croatian: Duloxetine Zentiva 60 mg želučanootporne tvrde kapsule EU/1/15/1028/004
English: Duloxetine may be associated with sedation and dizziness.
Croatian: Uzimanje duloksetina može biti povezano s pojavom sedacije i omaglice.
English: • have liver disease;
Croatian: • ako imate bolest jetre
English: Your doctor will tell you if you should be taking Duloxetine Zentiva.
Croatian: Liječnik će Vam reći smijete li uzimati Duloxetine Zentiva.
English: • painful urination, frequent urination;
Croatian: • bolno mokrenje, često mokrenje
English: drowsiness, clumsiness, restlessness, feeling of being drunk, fever, sweating or rigid muscles),
Croatian: nespretnost, nemir, osjećaj opijenosti, vrućicu, znojenje ili ukočenost mišića), napadaji
English: • weight loss.
Croatian: • gubitak tjelesne težine
English: Elevated liver enzymes (ALT, AST, alkaline phosphatase) Acute liver injury
Croatian: povišene vrijednosti jetrenih enzima (ALT, AST, alkalna fosfataza) akutno oštećenje jetre zatajenje jetre6 žutica6
English: Caution is advised if duloxetine is co-administered with medicinal products that are predominantly metabolised by CYP2D6 (risperidone, tricyclic antidepressants [TCAs] such as nortriptyline, amitriptyline, and imipramine) particularly if they have a narrow therapeutic index (such as flecainide, propafenone and metoprolol).
Croatian: Savjetuje se oprez ako se duloksetin primjenjuje istodobno s lijekovima koji se metaboliziraju prvenstveno pomoću CYP2D6 (risperidon, triciklički antidepresivi poput nortriptilina, amitriptilina i imipramina), naročito ako imaju uzak terapijski indeks (poput flekainida, propafenona i metoprolola).
English: Serotonin syndrome symptoms may include mental status changes (e.g., agitation, hallucinations, coma), autonomic instability (e.g., tachycardia, labile blood pressure, hyperthermia), neuromuscular aberrations (e.g. hyperreflexia, incoordination) and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhoea).
Croatian: Simptomi serotoninskog sindroma mogu uključivati promjene mentalnog statusa (npr. agitaciju, halucinacije, komu), nestabilnost autonomnog živčanog sustava (npr. tahikardiju, nestabilan krvni tlak, hipertermiju), neuromuskularne aberacije (npr. hiperrefleksiju, nekoordiniranost) i/ili gastrointestinalne simptome (npr. mučninu, povraćanje, proljev).
English: − Gelatin
Croatian: − želatina
English: Duloxetine demonstrated statistically significant superiority over placebo as measured by improvement in the Hamilton Anxiety Scale (HAM-A) total score and by the Sheehan Disability Scale (SDS) global functional impairment score.
Croatian: Duloksetin se pokazao statistički značajno superiornim u odnosu na placebo, mjereno ukupnim poboljšanjem na Hamiltonovoj ljestvici anksioznosti (HAM-A) i ukupnim funkcijskim oštećenjem prema Sheenanovoj ljestvici onesposobljenosti (engl.
English: Inducers of CYP1A2
Croatian: Induktori CYP1A2
English: • abnormal vaginal bleeding, abnormal periods, including heavy, painful, irregular or prolonged periods, unusually light or missed periods, pain in the testicles or scrotum;
Croatian: • nenormalno vaginalno krvarenje, nenormalne mjesečnice, uključujući obilne, bolne, neredovite ili produljene mjesečnice, neuobičajeno blage mjesečnice ili izostanak mjesečnice, bol u testisima ili mošnji
English: Duloxetine Zentiva must not be used in patients with severe renal impairment (creatinine clearance <30 ml/min; see section 4.3).
Croatian: Duloxetine Zentiva se ne smije primjenjivati u bolesnika s teškim oštećenjem bubrežne funkcije (klirens kreatinina < 30 ml/min; vidjeti dio 4.3).
English: Duloxetine 60 mg to 120 mg once daily demonstrated statistically significant superiority compared to placebo (p < 0.001) on the prevention of relapse, as measured by time to relapse.
Croatian: Duloksetin u dozi od 60 do 120 mg jednom dnevno bio je statistički značajno superioran u odnosu na placebo (p<0,001) u prevenciji relapsa, mjereno vremenom do pojave relapsa.
English: During 52 weeks of placebo-controlled double blind treatment, duloxetine-treated patients with recurrent MDD had a significantly longer symptom free period (p < 0.001) compared with patients randomised to placebo.
Croatian: Tijekom 52 tjedna placebom kontroliranog dvostruko slijepog ispitivanja, bolesnici s opetovanim velikim depresivnim poremećajem koji su primali duloksetin imali su značajno dulji period bez simptoma (p<0,001) u usporedbi s bolesnicima koji su primali placebo.
English: Mydriasis has been reported in association with duloxetine, therefore, caution should be used when prescribing Duloxetine Zentiva to patients with increased intraocular pressure, or those at risk of acute narrow-angle glaucoma.
Croatian: Prijavljeni su slučajevi midrijaze pri uzimanju duloksetina te se stoga Duloxetine Zentiva mora s oprezom propisivati bolesnicima s povišenim očnim tlakom i onima s rizikom za pojavu akutnog glaukoma uskog kuta.
English: In an open label long-term uncontrolled study, the pain reduction in patients responding to 8-weeks of acute treatment of duloxetine 60 mg once daily was maintained for a further 6-months as measured by change on the Brief Pain Inventory (BPI) 24-hour average pain item.
Croatian: U otvorenom dugotrajnom nekontroliranom ispitivanju smanjenje boli u bolesnika koji su reagirali na 8-tjedno akutno liječenje duloksetinom u dozi od 60 mg jednom dnevno održalo se tijekom sljedećih 6 mjeseci, mjereno promjenom 24-satnih podataka o prosječnoj boli u kratkom upitniku o boli (engl.
English: NAME OF THE MARKETING AUTHORISATION HOLDER Zentiva logo
Croatian: NAZIV NOSITELJA ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET Zentiva logo
English: The pharmacokinetics of theophylline, a CYP1A2 substrate, were not significantly affected by coadministration with duloxetine (60 mg twice daily).
Croatian: Nije bilo znatnijeg utjecaja na farmakokinetiku teofilina, koji je supstrat CYP1A2, prilikom istodobne primjene s duloksetinom (60 mg dva puta dnevno).
English: The main ingredient of Duloxetine Zentiva, duloxetine, is used in other medicines for other conditions: diabetic neuropathic pain, depression, anxiety and urinary incontinence.
Croatian: Duloksetin, glavni sastojak lijeka Duloxetine Zentiva, nalazi se i u nekim drugim lijekovima koji se koriste za liječenje drugih stanja: boli kod dijabetičke neuropatije, depresije, tjeskobe i inkontinencije mokraće.
English: • inflammation of the mouth, passing bright red blood in your stools, bad breath, inflammation of the large intestine (leading to diarrhoea);
Croatian: • upala usta, svjetlocrvena krv u stolici, neugodan zadah, upala debelog crijeva (što dovodi do proljeva)
English: After an intravenous dose the plasma clearance of duloxetine ranges from 22 l/h to 46 l/h (mean of 36 l/h).
Croatian: Klirens duloksetina iz plazme nakon intravenski primijenjene doze kreće se u rasponu od 22 l/h do 46 l/h (srednja vrijednost 36 l/h).
English: • liver failure, yellowing of the skin or whites of the eyes (jaundice);
Croatian: • zatajenje jetre, žutilo kože ili bjeloočnica (žutica)
English: • chest pain, feeling cold, thirst, shivering, feeling hot, abnormal gait;
Croatian: • bol u prsnom košu, osjećaj hladnoće, žeđ, drhtanje, osjećaj vrućine, nenormalan hod
English: If you stop taking Duloxetine Zentiva
Croatian: Ako prestanete uzimati Duloxetine Zentiva
English: The initiation of treatment with Duloxetine Zentiva is contraindicated in patients with uncontrolled hypertension that could expose patients to a potential risk of hypertensive crisis (see sections 4.4 and
Croatian: Kontraindicirano je započeti liječenje lijekom Duloxetine Zentiva u bolesnika s nekontroliranom hipertenzijom koja bolesnika može izložiti potencijalnom riziku od hipertenzivne krize (vidjeti dijelove 4.4 i 4.8).
English: The effect of duloxetine 60 mg once a day in elderly depressed patients (≥ 65 years) was specifically examined in a study that showed a statistically significant difference in the reduction of the HAMD17 score for duloxetine-treated patients compared to placebo.
Croatian: Učinak duloksetina u dozi od 60 mg jednom dnevno u starijih depresivnih bolesnika (≥ 65 godina) posebno je ispitivan u ispitivanju koje je pokazalo statistički značajnu razliku u smanjenju broja bodova na HAMD17 ljestvici u bolesnika liječenih duloksetinom u odnosu na one koji su uzimali placebo.
English: Data on the use of duloxetine 120 mg in elderly patients with major depressive disorder and generalised anxiety disorder are limited.
Croatian: Postoje samo ograničeni podaci o primjeni duloksetina u dozi od 120 mg u starijih osoba s velikim depresivnim poremećajem i generaliziranim anksioznim poremećajem.
English: Duloxetine Zentiva must not be used in patients with liver disease resulting in hepatic impairment (see sections 4.3 and 5.2).
Croatian: Duloxetine Zentiva se ne smije davati bolesnicima s bolešću jetre čija je posljedica oštećenje jetrene funkcije (vidjeti dijelove 4.3 i 5.2).
English: Duloxetine 60 mg once daily demonstrated a statistically significant superiority compared to placebo (p=0.004) on the primary outcome measure, the prevention of depressive relapse, as measured by time to relapse.
Croatian: Duloksetin u dozi od 60 mg jednom dnevno bio je statistički značajno superioran u usporedbi s placebom (p=0,004) s obzirom na primarnu mjeru ishoda - prevenciju relapsa depresije, mjereno vremenom do pojave relapsa.
English: Pharmacokinetics of duloxetine in paediatric patients aged 7 to 17 years with major depressive disorder following oral administration of 20 to 120 mg once daily dosing regimen was characterized using population modelling analyses based on data from 3 studies.
Croatian: Farmakokinetika duloksetina nakon peroralne primjene doze od 20-120 mg jedanput na dan u pedijatrijskih bolesnika u dobi od 7 do 17 godina s velikim depresivnim poremećajem okarakterizirana je uz pomoć analiza populacijskih modela na temelju podataka iz 3 ispitivanja.
English: Duloxetine Zentiva may make you feel sleepy or dizzy.
Croatian: Duloxetine Zentiva može izazvati pospanost ili omaglicu.
English: • suicidal thoughts, difficulty sleeping, grinding or clenching the teeth, feeling disorientated, lack of motivation;
Croatian: • samoubilačke misli, tegobe sa spavanjem, škripanje ili stiskanje zubima, dezorijentiranost,
English: • dizziness, feeling sluggish, tremor, numbness, including numbness, pricking or tingling of the skin;
Croatian: • omaglica, tromost, nevoljno drhtanje, utrnulost, uključujući obamrlost, bockanje ili trnci na koži
English: In clinical trials adverse events seen on abrupt treatment discontinuation occurred in approximately 45% of patients treated with duloxetine and 23% of patients taking placebo.
Croatian: U kliničkim su se ispitivanjima nuspojave nakon naglog prekida liječenja pojavile u približno 45% bolesnika liječenih duloksetinom i u 23% bolesnika koji su uzimali placebo.
English: After an oral dose the apparent plasma clearance of duloxetine ranges from 33 to 261 l/h (mean 101 l/h).
Croatian: Prividni klirens duloksetina iz plazme nakon peroralno primijenjene doze kreće se u rasponu od 33 do 261 l/h (srednja vrijednost 101 l/h).
English: • increased sweating, (itchy) rash;
Croatian: • pojačano znojenje, osip (koji svrbi)
English: • Medicines that increase the level of serotonin: Triptans, tramadol, tryptophan, SSRIs (such as paroxetine and fluoxetine), SNRIs (such as venlafaxine), tricyclic antidepressants (such as clomipramine, amitriptyline), pethidine, St. John's Wort and MAOIs (such as moclobemide and linezolid).
Croatian: • lijekove koji povećavaju razinu serotonina: Triptani, tramadol, triptofan, selektivni inhibitori ponovne pohrane serotonina (poput paroksetina i fluoksetina), inhibitori ponovne pohrane serotonina i noradrenalina (poput venlafaksina), triciklički antidepresivi (poput klomipramina, amitriptilina), petidin, gospina trava i inhibitori MAO (poput moklobemida i linezolida).
English: The efficacy of duloxetine at the recommended dose of 60 mg once a day was demonstrated in three out of three randomised, doubleblind, placebo-controlled, fixed dose acute studies in adult outpatients with major depressive disorder.
Croatian: Djelotvornost duloksetina pri preporučenoj dozi od 60 mg jednom dnevno pokazana je u tri od tri randomizirana, dvostruko slijepa, placebom kontrolirana kratkoročna ispitivanja fiksnih doza u odraslih ambulantno liječenih bolesnika s velikim depresivnim poremećajem.
English: If you forget to take Duloxetine Zentiva
Croatian: Ako ste zaboravili uzeti Duloxetine Zentiva
English: • dizziness, tingling, feelings like pins and needles or electric shock-like feelings (particularly in the head), sleep disturbances (vivid dreams, nightmares, inability to sleep), fatigue, sleepiness, feeling restless or agitated, feeling anxious, feeling sick (nausea) or being sick (vomiting), shaking (tremor), headaches, muscle pain, feeling irritable, diarrhoea, excessive sweating or vertigo.
Croatian: • omaglica, trnci ili osjeti nalik strujnom udaru (osobito u glavi), smetnje spavanja (živopisni snovi, noćne more, nemogućnost spavanja), umor, pospanost, nemir ili uznemirenost, tjeskoba, mučnina ili povraćanje, nevoljno drhtanje (tremor), glavobolja, bol u mišićima, razdražljivost, proljev, prekomjerno znojenje ili vrtoglavica.
English: Caution is advisable if duloxetine is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St. John's wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Croatian: Preporučuje se oprez ako se duloksetin primjenjuje istodobno sa serotoninergičkim lijekovima poput SSRI-ja, SNRI-ja, tricikličkih antidepresiva poput klomipramina i amitriptilina, inhibitora MAO poput moklobemida ili linezolida, gospine trave (Hypericum perforatum) ili triptana, tramadola, petidina i triptofana (vidjeti dio 4.4).
English: You must wait at least 14 days after you have stopped taking an MAOI before you can take Duloxetine Zentiva.
Croatian: Nakon što ste prestali uzimati inhibitor MAO, morate pričekati najmanje 14 dana prije nego počnete uzimati Duloxetine Zentiva.
English: • are taking other medicines containing duloxetine (see ‘Other medicines and Duloxetine Zentiva')
Croatian: • ako uzimate druge lijekove koji sadrže duloksetin (pogledajte „Drugi lijekovi i Duloxetine Zentiva“).
English: Gastro-resistant hard capsule
Croatian: Želučanootporna tvrda kapsula
English: How to take Duloxetine Zentiva
Croatian: Kako uzimati Duloxetine Zentiva
English: Medicinal products metabolised by CYP1A2
Croatian: Lijekovi koji se metaboliziraju pomoću CYP1A2
English: INFORMATION IN BRAILLE Duloxetine Zentiva 30 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Duloxetine Zentiva 30 mg
English: • are taking other medicines containing duloxetine (see ‘Other medicines and Duloxetine
Croatian: • ako uzimate druge lijekove koji sadrže duloksetin (pogledajte ‘Drugi lijekovi i Duloxetine
English: • have had seizures (fits);
Croatian: • ako ste imali napadaje (konvulzije)
English: Also, you need to wait at least 5 days after you stop taking Duloxetine Zentiva before you take a MAOI.
Croatian: Također, nakon što ste prestali uzimati Duloxetine Zentiva, morate pričekati najmanje 5 dana prije nego počnete uzimati inhibitor MAO.
English: • throat inflammation that causes a hoarse voice;
Croatian: • upala grla koja uzrokuje promuklost
English: Concomitant use of Duloxetine Zentiva with nonselective, irreversible monoamine oxidase inhibitors (MAOIs) is contraindicated (see section 4.5).
Croatian: Kontraindicirana je istodobna primjena lijeka Duloxetine Zentiva s neselektivnim, ireverzibilnim inhibitorima monoaminooksidaze (MAOI) (vidjeti dio 4.5).
English: How to store Duloxetine Zentiva
Croatian: Kako čuvati Duloxetine Zentiva
English: Duloxetine Zentiva contains the active substance duloxetine.
Croatian: Duloxetine Zentiva sadrži djelatnu tvar duloksetin.
English: INFORMATION IN BRAILLE Duloxetine Zentiva 60 mg
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Duloxetine Zentiva 60 mg
English: Duloxetine Zentiva gastro-resistant hard capsules contain sucrose.
Croatian: Duloxetine Zentiva želučanootporne tvrde kapsule sadrže saharozu.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Duloxetine Zentiva 30 mg gastro-resistant hard capsules Each capsule contains duloxetine hydrochloride equivalent to 30 mg duloxetine.
Croatian: KVALITATIVNI I KVANTITATIVNI SASTAV Duloxetine Zentiva 30 mg želučanootporne tvrde kapsule Jedna kapsula sadrži 30 mg duloksetina u obliku duloksetinklorida.